Trilogy Capital’s ProShares Ultra MSCI Emerging Markets EET Stock Holding History

Trilogy Capital’s Portfolio EET Stock Details EET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-51	Closed	-$4K	–	255
2018 Q3	$4K	Hold	51	–	–	﹤0.01%	423
2018 Q2	$4K	Hold	51	–	–	﹤0.01%	384
2018 Q1	$5K	Buy	+51	New	+$5.14K	﹤0.01%	311

Other funds holding EET

Pension Partners New York $72.6M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

DBT

Dubuque Bank & Trust Dubuque, Iowa $748M AUM 12.31% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Trilogy Capital's EET Position: Q4 2018 in Review

Trilogy Capital sold out of ProShares Ultra MSCI Emerging Markets (EET) in Q4 2018, closing a stake of 51 shares — an estimated $4K sold.

Trilogy Capital first reported a position in EET in Q1 2018 and held it in 3 quarters. The position peaked at $5K in Q1 2018. 12 funds tracked by Wall St. Rank hold EET as of Q4 2018.

Trilogy Capital reported no remaining ProShares Ultra MSCI Emerging Markets position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 51 ProShares Ultra MSCI Emerging Markets shares in Q4 2018, an estimated $4K.
Trilogy Capital first reported a position in ProShares Ultra MSCI Emerging Markets in Q1 2018 and held it in 3 quarters.
Trilogy Capital's ProShares Ultra MSCI Emerging Markets position peaked at $5K in Q1 2018.
12 funds tracked by Wall St. Rank held ProShares Ultra MSCI Emerging Markets as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.